Yellow Card Scheme UK
Published: 6th August 2026
The Yellow Card Scheme in the UK is a system for collecting and monitoring information about suspected adverse drug reactions and safety concerns related to medicines and medical devices.
It allows anyone to report issues with medicines, vaccines, medical devices, and e-cigarettes. Established as the world's first spontaneous reporting scheme, it plays a crucial role in post-marketing drug safety surveillance in the UK, having collected over 1 million reports since its inception. For more information, you can visit the official Yellow Card website.
Frequently Asked Questions (FAQs)
-
The Yellow Card Scheme is the UK system for collecting and monitoring information about suspected adverse drug reactions and other safety concerns relating to medicines and medical devices. It supports post-marketing safety surveillance, helping to identify issues that may not have been apparent during clinical trials.
-
Reports can cover medicines, vaccines, medical devices and e-cigarettes. Anyone can submit one, including healthcare professionals, patients, carers and members of the public. You don't need to be certain that a medicine or device caused the problem, as suspicion alone is enough to warrant a report.
-
The scheme was the world's first spontaneous reporting system of its kind and has collected over a million reports since it began. Every report contributes to the wider safety picture, and patterns identified through the scheme can lead to changes in how medicines and devices are used or licensed. Further information is available on the official Yellow Card website at yellowcard.mhra.gov.uk.
If you have completed your Community Pharmacy Independent Prescribing Training on the Community Pharmacy Scotland (CPS) / PSD Scotland (formerly NES) Programme, a Teach & Treat (T&T) session at one of the hubs is included as part of your programme.
Seriouse Shortage Protocols for selected Estradot® patches and Creon® capsules have been extended until 8th January 2027.
This week’s MCR Ready Reckoner has been updated and is now available to download or you can view it via the App.
Practical guidance to help pharmacy teams avoid courier collection issues and ensure prescription bags are collected correctly.
October 2026 Scottish Drug Tariff changes including Part 7 additions, deletions and updates to adjusted price arrangements.
The Sustainable Prescribing and Therapeutics Programme, are seeking examples of best practice in effective medicines use and approaches on reducing medicines waste within different healthcare settings
New drug death figures reinforce the need for a nationally commissioned substance use service and a stronger role for community pharmacy.
Updates to the NHS Pharmacy First Scotland Approved List from October 2026, including new formulary entries and eczema products.
Community Pharmacy Scotland (CPS) has agreed a funding settlement with the Scottish Government for 2026/27, providing increased funding certainty for Scotland's community pharmacy network.
Details of the 2026/27 community pharmacy funding package, including Global Sum, guaranteed funding and remuneration arrangements.
The Scottish Parliament recently debated the growing challenge of health misinformation, including its impact on public confidence in healthcare and vaccination programmes.
Important information on Post Registration Foundation Training and Community Pharmacist Independent Prescriber training opportunities.
Applications are open until 30 September 2026 for the Post-Registration Programme for Pharmacists (Scotland).
A reminder for contractors to review PVG Scheme membership records and ensure relevant pharmacy staff are correctly linked to their employer.
A new Video Remote Interpreting pilot will launch in community pharmacies on 5 October 2026 to support BSL users accessing services.
Guidance on the 2026/27 winter flu and COVID-19 vaccination programme, including eligibility, timings, vaccine products and delivery arrangements.
The opportunities and risks for community pharmacy as Scotland considers major NHS structural reform.
New GPhC advice highlights key considerations for newly qualified prescribing pharmacists, employers and managers.
The opportunities and risks for community pharmacy as Scotland considers major NHS structural reform.
Please find below the NHS Circulars PCA(P)(2026)14 and PCA(P)(2026)15, advising that Serious Shortage Protocols (SSPs) are in place to help mitigate supply issues affecting lansoprazole 15mg and 30mg orodispersible tablets.
Our colleagues at the British Society of Pharmacy Sleep Services have spent some time with us to highlight and explain their participation in AWAKE Check study and tool.
The Community Pharmacy Network included in the Scottish Government Health and Care Improving Flow Plan.
NHS 24 is promoting student health resources covering NHS services, vaccinations, mental health, sexual health and primary care.
The programme (Supporting documents - Programme for Government 2026 to 2031 - gov.scot) proposes radical reshaping of Scotland’s public services, focusing on structural reform rather than just new spending or isolated policy pledges.
Community Pharmacy Scotland’s response to the UK-wide consultation on Tobacco and Vapes: Packaging, Appearance and Display.
The GPhC is reviewing the route to registration in Great Britain for pharmacists who qualified outside the EEA, the EFTA countries and Switzerland.
The CPS Charity Golf Day 2026 raised a record-breaking £10,063.32 for Blood Bikes Scotland.
Over recent weeks we have seen a growing number of enquiries from members of the public asking us to provide the NHS PFS service, with the pattern most pronounced in the evenings and at weekends.
Our colleagues at PSDS have shared with us the link to their latest podcast, where the guests speak through early careers development for Pharmacists in Scotland
Digital Communications Officer

Our colleagues at the GPhC Inspectorate have asked us to pass on a friendly reminder as to the procedures required for Community Pharmacies to appropriately deal with Private Prescriptions for Controlled Drugs.